Location History:
- New York, NY (US) (1998 - 2000)
- York, NY (US) (2002)
Company Filing History:
Years Active: 1998-2002
Title: Gerd Grieninger: Innovator in Fibrinogen Research
Introduction
Gerd Grieninger is a notable inventor based in New York, NY (US). He has made significant contributions to the field of fibrinogen research, holding a total of 4 patents. His work focuses on the detection and purification of fibrinogen fragments, which has important implications for medical diagnostics and treatment.
Latest Patents
Grieninger's latest patents include innovative methods for detecting and purifying novel α CX cleavage fragments of fibrinogen. This invention provides a diagnostic method for determining fibrinolytic states or atherogenesis in mammals. Additionally, it includes methods for treating diseases characterized by fibrinogen metabolism. His patents also encompass the development of monospecific antibodies that are specifically reactive with the α C domain of fibrinogen, as well as DNA and RNA molecules encoding these cleavage fragments. Another significant patent involves monospecific antibodies reactive with the α.hd E subunit of fibrinogen, which are crucial for detecting information related to atherogenesis, thrombogenesis, and pregnancy outcomes.
Career Highlights
Gerd Grieninger is associated with the New York Blood Center, Inc., where he continues to advance research in fibrinogen and its clinical applications. His work has been instrumental in developing diagnostic tools that enhance our understanding of various medical conditions.
Collaborations
Grieninger has collaborated with notable colleagues, including Yiping Fu and Yan Cao, contributing to the advancement of research in his field.
Conclusion
Gerd Grieninger's innovative work in fibrinogen research has led to significant advancements in medical diagnostics and treatment options. His contributions continue to impact the field positively, showcasing the importance of innovation in healthcare.